Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v9-FR
Language English French
Date Updated 2019-06-20 2019-01-31
Drug Identification Number 02382482 02382482
Brand name NALOXONE HYDROCHLORIDE INJECTION USP NALOXONE HYDROCHLORIDE INJECTION USP
Common or Proper name NALOXONE HYDROCHLORIDE INJECTION NALOXONE HYDROCHLORIDE INJECTION
Company Name TELIGENT OU TELIGENT OU
Ingredients NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG 0.4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1 ML 1 ML
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2018-10-30 2018-10-30
Estimated end date 2019-06-21 2019-04-30
Actual end date 2019-06-19
Shortage status Resolved Actual shortage
Company comments
Health Canada comments